Axxess Pharma Inc (OTCMKTS:AXXE) has announced that the company management has projected a strong second-half of 2015 for the company. Axxess has mostly been busy in the first-half of the year conducting aggressive marketing and acquiring global approvals for its Tapout Supplements. The supplements are for pain and extreme muscles.
The company’s most recent accomplishments include becoming the official fitness and training partner for the WWE and the approval by health Canada to sell the supplements in the country. The moves have already resulted in an increase in sales, Amazon placing a new order with the company for more supplements. The Tapout pain relief spray allows athletes to train despite the pain. The formula for all Tapout drugs is composed of natural ingredients and allows consumers to push the body to its limits, while still giving rest to the injured area.
Getting the approval from Health Canada was one of the toughest challenge for Axxess, which after a long period of waiting, should result in a tremendous increase in revenues. It is important to note here that Canada is considered the largest market for health and fitness products. The company has already begun their aggressive marketing campaigns in Canada and they would be present at the Toronto Super Show as well. Axxess will have its own stall at the largest health and fitness convention, which is also attended by other leading brands.
Axxess has planned to use this opportunity to meet with a number of distributors and retailers in the US and Canada, so as to maximize their market potential. Additionally, the company’s current links in the health and fitness industry gives them access to meeting with a number of athletes and event organizers to get their products promoted.
Axxess Pharma Inc (OTCMKTS:AXXE) lost 10.07% of its share value to close at a share price of $0.0241, at the end of the June 29 session after trading a total of 4.87 million shares in the market.